Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Oncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic oncolytic agents that would generate durable and multifaceted anti-tumor immune responses to disrupt the tumors. He...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncoimmunology
Hlavní autoři: Luo, Yong, Lin, Chaolong, Zou, Yidi, Ju, Fei, Ren, Wenfeng, Lin, Yanhua, Wang, Yale, Huang, Xiaoxuan, Liu, Huiling, Yu, Zeng, Liu, Pingguo, Tan, Guowei, Yuan, Quan, Zhang, Jun, Huang, Chenghao, Xia, Ningshao
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028326/
https://ncbi.nlm.nih.gov/pubmed/32117591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1726168
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky